The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Naproxen Sodium
Naproxen Sodium, Coated Tablets · NAPROXEN SODIUM 220 mg/1 · Tablet · Oral · Marksans Pharma Limited
NDC 25000-0141-02 · 160 CARTON in 1 BOX / 1 BOTTLE in 1 CARTON / 24 TABLET in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for naproxen sodium (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market · price up 1% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA090545
- TE code
- —
- Approval date
- Mar 16, 2011
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Naproxen Sodium, Coated Tablets (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Marksans Pharma Limited | NAPROXEN SODIUM 220 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Naproxen Sodium — NDC 25000-0141-02," retrieved September 3, 2026, https://drugdashboards.com/drug/25000014102.
Free to cite with attribution — see how the data is put together.